Live Breaking News & Updates on Bellicum pharmaceuticals inc

Stay updated with breaking news from Bellicum pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bellicum Pharmaceuticals (NASDAQ:BLCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % Shares of BLCM opened at $0.07 on Friday. The business’s 50 day moving average is $0.08 and […]

United-states , Bellicum-pharmaceuticals-stock-down , Bellicum-pharmaceuticals , Bellicum-pharmaceuticals-inc , Bellicum-pharmaceuticals-company-profile , News-ratings-for-bellicum-pharmaceuticals-daily , Boxer-capital , Nasdaq , Free-report , Pharmaceuticals-stock-down , Get-free-report

StockNews.com Initiates Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)

StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % NASDAQ:BLCM opened at $0.07 on Friday. The stock’s 50-day simple moving average is $0.08 and its 200 […]

United-states , Bellicum-pharmaceuticals-stock-down , Bellicum-pharmaceuticals , Institutional-trading-of-bellicum-pharmaceuticals , Bellicum-pharmaceuticals-inc , Bellicum-pharmaceuticals-company-profile , News-ratings-for-bellicum-pharmaceuticals-daily , Exchange-commission , Boxer-capital , Nasdaq , Free-report

StockNews.com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)

StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 6.6 % Shares of BLCM stock opened at $0.07 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a […]

United-states , Boxer-capital , Bellicum-pharmaceuticals-trading-down , Institutional-investors-weigh-in-on-bellicum-pharmaceuticals , Securities-exchange-commission , Bellicum-pharmaceuticals , Nasdaq , Bellicum-pharmaceuticals-inc , News-ratings-for-bellicum-pharmaceuticals-daily , Free-report , Pharmaceuticals-trading-down

Bellicum Pharmaceuticals (NASDAQ:BLCM) Receives New Coverage from Analysts at StockNews.com

Bellicum Pharmaceuticals (NASDAQ:BLCM) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Institutional-investors-weigh-in-on-bellicum-pharmaceuticals , Bellicum-pharmaceuticals , Nasdaq , Bellicum-pharmaceuticals-inc , News-ratings-for-bellicum-pharmaceuticals-daily , Bellicum-pharmaceuticals-trading-down , Securities-exchange-commission , Boxer-capital , Free-report , Pharmaceuticals-trading-down

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

University-of-texas , Texas , United-states , Bellicum-go , Katy-rezvani , Philip-jones , Cancer-center , Drug-administration , Research-strategy , Bellicum-pharmaceuticals-inc , Anderson-cancer , Bellicum-pharmaceuticals

MD Anderson acquires inducible switch technologies for cell therapy

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may in

Houston , Texas , United-states , University-of-texas , Philip-jones , Katy-rezvani , Bellicum-go , Bellicum-pharmaceuticals-inc , Drug-administration , Cancer-center , Research-strategy , Bellicum-pharmaceuticals

MD Anderson acquires inducible switch technologies for cell therapy

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may in

Houston , Texas , United-states , University-of-texas , Bellicum-go , Philip-jones , Katy-rezvani , Drug-administration , Research-strategy , Cancer-center , Bellicum-pharmaceuticals-inc , Bellicum-pharmaceuticals

MD Anderson Secures Inducible Switch Tech for Cell Therapy

MD Anderson Secures Inducible Switch Tech for Cell Therapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , Bellicum-go , Philip-jones , Katy-rezvani , Drug-administration , Research-strategy , University-of-texas-md-anderson-cancer-center , Bellicum-pharmaceuticals-inc , Cancer-center , Bellicum-pharmaceuticals , Therapeutics-discovery

StockNews.com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)

StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Performance Shares of BLCM opened at $0.09 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a 12 month high […]

United-states , Nasdaq , News-ratings-for-bellicum-pharmaceuticals-daily , Bellicum-pharmaceuticals-company-profile , Exchange-commission , Bellicum-pharmaceuticals-stock-performance , Bellicum-pharmaceuticals-inc , Institutional-trading-of-bellicum-pharmaceuticals , Bellicum-pharmaceuticals , Free-report , Get-free-report

Bellicum Pharmaceuticals (NASDAQ:BLCM) Coverage Initiated at StockNews.com

Bellicum Pharmaceuticals (NASDAQ:BLCM) Coverage Initiated at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Bellicum-pharmaceuticals-trading-down , News-ratings-for-bellicum-pharmaceuticals-daily , Bellicum-pharmaceuticals , Nasdaq , Securities-exchange-commission , Bellicum-pharmaceuticals-company-profile , Bellicum-pharmaceuticals-inc , Free-report , Pharmaceuticals-trading-down , Get-free-report